STOCK TITAN

Nutex Health (NUTX) director acquires 603 shares through RSU conversion

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Nutex Health Inc. director Frank E. Jaumot reported acquiring 603 shares of Common Stock on July 31, 2026 through the exercise or conversion of a derivative security. A related footnote explains that restricted stock units convert into common stock on a one-for-one basis. After this transaction, he directly owns 753 shares.

Positive

  • None.

Negative

  • None.
Insider Jaumot Frank E
Role Director
Type Security Shares Price Value
Exercise Common Stock F1 603 $0.00 $0.00
Holdings After Transaction: Common Stock — 753 shares (Direct)
Footnotes (1)
  1. F1. Restricted stock units convert into common stock on a one-for-one basis.
Shares acquired 603 shares Common Stock acquired on July 31, 2026 via derivative conversion
Price per share $0.00 per share Reported transaction price for the 603 Common Stock shares
Shares owned after 753 shares Direct Common Stock ownership following the transaction
Transaction date July 31, 2026 Date of derivative exercise or conversion into Common Stock
Restricted stock units financial
"Restricted stock units convert into common stock on a one-for-one basis."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative security financial
"Transaction code M: Exercise or conversion of derivative security."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Common Stock financial
"Security title reported as Common Stock in the transaction."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction involving Nutex Health (NUTX) did Frank E. Jaumot report?

Frank E. Jaumot reported acquiring 603 shares of Nutex Health Common Stock on July 31, 2026. The shares came from the exercise or conversion of restricted stock units that convert into common stock on a one-for-one basis, increasing his direct holdings to 753 shares.

How many Nutex Health (NUTX) shares did director Frank E. Jaumot acquire and at what price?

Frank E. Jaumot acquired 603 Nutex Health Common shares at a reported price of $0.00 per share. The shares were received through the exercise or conversion of restricted stock units rather than a market purchase, according to the transaction details and accompanying footnote.

What is Frank E. Jaumot’s Nutex Health (NUTX) share ownership after the reported transaction?

After the reported transaction, Frank E. Jaumot directly owns 753 shares of Nutex Health Common Stock. This reflects the addition of 603 shares acquired on July 31, 2026 through the exercise or conversion of restricted stock units into common stock on a one-for-one basis.

What type of equity award was involved in the recent Nutex Health (NUTX) insider transaction?

The transaction involved restricted stock units (RSUs) that convert into Nutex Health Common Stock on a one-for-one basis. These RSUs were exercised or converted, resulting in the issuance of 603 common shares to director Frank E. Jaumot and increasing his direct ownership to 753 shares.

On what date did the Nutex Health (NUTX) insider equity conversion for Frank E. Jaumot occur?

The equity conversion for Frank E. Jaumot occurred on July 31, 2026. On that date, restricted stock units converted into 603 shares of Nutex Health Common Stock, as reported in the insider transaction, bringing his direct holdings to a total of 753 shares.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Jaumot Frank E

(Last)(First)(Middle)
1776 YORKTOWN STREET SUITE 700
C/O NUTEX HEALTH INC.

(Street)
HOUSTON TEXAS 77056

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Nutex Health Inc. [ NUTX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/31/2026M603A$0(1)753D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Restricted stock units convert into common stock on a one-for-one basis.
/s/ Frank E. Jaumot08/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)